Seeing Is Believing
Currently out of the existing stock ratings of Matthew Caufield, 175 are a BUY (90.21%), 19 are a HOLD (9.79%).
Analyst Matthew Caufield, carries an average stock price target met ratio of 26.3% that have a potential upside of 32.22% achieved within 75 days.
Matthew Caufield’s has documented 348 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on KOD, Kodiak Sciences at 12-Oct-2026.
Analyst best performing recommendations are on KOD (KODIAK SCIENCES).
The best stock recommendation documented was for ALDX (ALDEYRA THE) at 3/18/2026. The price target of $2 was fulfilled within 5 days with a profit of $0.58 (40.85%) receiving and performance score of 81.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Sep-2026
$2
$0.83 (70.94%)
$2
19 days ago
(30-Sep-2026)
1/8 (12.5%)
$0.77 (62.60%)
5
Buy Since 04-Nov-2021
$9
$7.83 (669.23%)
$9
20 days ago
(29-Sep-2026)
0/8 (0%)
$7.68 (581.82%)
Buy Since 30-Oct-2020
$7
$5.17 (282.51%)
$6
1 years 11 days ago
(08-Oct-2025)
0/4 (0%)
$1.38 (24.56%)
Buy Since 28-Mar-2024
$9
$7.17 (391.80%)
1 years 2 months 11 days ago
(08-Aug-2025)
0/2 (0%)
$3.74 (71.10%)
Buy Since 03-Oct-2024
$12
$10.83 (925.64%)
$12
1 years 10 months 3 days ago
(16-Dec-2024)
3/8 (37.5%)
$6.94 (137.15%)
362
Which stock is Matthew Caufield most bullish on?
Which stock is Matthew Caufield most reserved on?